1,664
Participants
Start Date
November 3, 2014
Primary Completion Date
July 21, 2017
Study Completion Date
July 21, 2017
Procalcitonin level
A procalcitonin (PCT) will be drawn level within one hour after randomization in the ED, and if hospitalized, 6-24 hours after the initial ED blood draw, and on Days 3, 5, and 7. Days 3, 5, and 7 blood draws for procalcitonin will only occur in hospitalized patients on antibiotics and/or at the treating physician's discretion.
Results of procalcitonin (PCT) level to treating clinician
In the ED, we will quickly (\<1 hour goal) provide clinicians the procalcitonin result.
Provide procalcitonin guideline to treating clinician
"Procalcitonin antibiotic guideline --~Procalcitonin level (ug/L) -- Bacterial etiology -- Recommendation~\< 0.1 -- Very unlikely -- Antibiotics strongly discouraged(1)~0.1 - 0.25 -- Unlikely -- Antibiotics discouraged(1)~\> 0.25 - 0.5 -- Likely -- Antibiotics recommended(2)~\> 0.5 -- Very likely -- Antibiotics strongly recommended(2)~1. Initial antibiotics can be considered for critical illness, Legionella pneumophilia. Procalcitonin should be evaluated in context with all findings and the total clinical status; clinical judgment always necessary.~2. For outpatients, antibiotic duration based on level (\> 0.25-0.5 ug/L:3 days; \> 0.5-1.0 ug/L:5 days; \>1.0 ug/L:7 days). Physician follow-up is recommended."
Telephone Visit
We will collect the number of antibiotic days during telephone visits occurring on or around Day 15 and Day 30
University of Pittsburgh Medical Center, Pittsburgh
Penn State Hershey College of Medicine; Milton S. Hershey Medical Center, Hershey
University of Maryland/Baltimore, Baltimore
University of Alabama at Birmingham, Birmingham
The Ohio State University, College of Medicine, Columbus
Wayne State University/Detroit Receiving Hospital, Detroit
Essentia Institute of Rural Health, Duluth
Maricopa Medical Center, Phoenix
University of California at Irvine Medical Center, Orange
Norwalk Hospital, Norwalk
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
National Institute of General Medical Sciences (NIGMS)
NIH
BioMérieux
INDUSTRY
University of Pittsburgh
OTHER